Qiagen Names Jonathan Pratt as CEO as Sale Talks Progress
Qiagen NV has appointed Jonathan Pratt as its new chief executive officer amid ongoing negotiations with private equity firms regarding a potential sale of the company. The leadership change comes as the European molecular testing company explores strategic options to enhance its market position. This appointment suggests the company is preparing for significant transitions ahead.
Readers say
How does this story lean?
Outlet ratings above are Trace's curated source map. Vote here (same as on the home feed) — one vote per browser, changeable anytime. Rate individual outlets in the coverage list below.
Comments
0No comments yet. Say what you noticed in the coverage.
Trending